GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » Return-on-Tangible-Equity

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Return-on-Tangible-Equity : 0.00% (As of Jun. 2020)


View and export this data going back to 2005. Start your Free Trial

What is Cannabis Strategic Ventures Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Cannabis Strategic Ventures's annualized net income for the quarter that ended in Jun. 2020 was $-5.69 Mil. Cannabis Strategic Ventures's average shareholder tangible equity for the quarter that ended in Jun. 2020 was $-6.37 Mil. Therefore, Cannabis Strategic Ventures's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2020 was N/A%.

The historical rank and industry rank for Cannabis Strategic Ventures's Return-on-Tangible-Equity or its related term are showing as below:

NUGS's Return-on-Tangible-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.31
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Cannabis Strategic Ventures Return-on-Tangible-Equity Historical Data

The historical data trend for Cannabis Strategic Ventures's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Strategic Ventures Return-on-Tangible-Equity Chart

Cannabis Strategic Ventures Annual Data
Trend Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20
Return-on-Tangible-Equity
Get a 7-Day Free Trial - Negative Tangible Equity -2,097.26 -3,533.88 -

Cannabis Strategic Ventures Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cannabis Strategic Ventures's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Strategic Ventures's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's Return-on-Tangible-Equity falls into.



Cannabis Strategic Ventures Return-on-Tangible-Equity Calculation

Cannabis Strategic Ventures's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2020 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2020 )  (A: Mar. 2019 )(A: Mar. 2020 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2020 )  (A: Mar. 2019 )(A: Mar. 2020 )
=-9.055/( (0.323+-5.852 )/ 2 )
=-9.055/-2.7645
=N/A %

Cannabis Strategic Ventures's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2020 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2020 )  (Q: Mar. 2020 )(Q: Jun. 2020 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2020 )  (Q: Mar. 2020 )(Q: Jun. 2020 )
=-5.692/( (-5.852+-6.881)/ 2 )
=-5.692/-6.3665
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2020) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Cannabis Strategic Ventures  (OTCPK:NUGS) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Cannabis Strategic Ventures Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Traded in Other Exchanges
N/A
Address
9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.
Executives
Gordon Samson director, officer: Chief Financial Officer 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown director, officer: VP, Corporate Development 9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster director, officer: CFO, Secretary & Treasurer 5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler director, 10 percent owner, officer: President #604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman director, 10 percent owner, officer: SECRETARY/TREASURER 5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall director, 10 percent owner, officer: President 2435 WEST 7TH AVENUE VANCOUVER A1 00000